Clinical Experience With Certican® (Everolimus) in De Novo Heart Transplant Patients at the Deutsches Herzzentrum Berlin
Author:
Publisher
Elsevier BV
Subject
Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference20 articles.
1. Seventeen-year experience with 1,083 heart transplants at a single institution;Marelli;Ann Thorac Surg,2002
2. Recent trends in early outcome of adult patients after heart transplantation;Tsai;Am J Transplant,2002
3. Mortality rates after heart transplantation;Smits;Transplantation,2003
4. The role of donor age and ischemic time on survival following orthotopic heart transplantation;Del Rizzo;J Heart Lung Transplant,1999
5. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?;Kobashigawa;Curr Control Trials Cardiovasc Med,2000
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Early Everolimus Initiation Fails to Counteract the Cytotoxic Response Mediated by CD8+ T and NK Cells in Heart Transplant Patients;Frontiers in Immunology;2018-09-26
2. Chronic Renal Insufficiency in Heart Transplant Recipients: Risk Factors and Management Options;Drugs;2014-08-19
3. Prospective Study of Everolimus With Calcineurin Inhibitor-Free Immunosuppression After Heart Transplantation: Results at Four Years;The Annals of Thoracic Surgery;2014-03
4. Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now?;Transplantation Reviews;2013-07
5. State of the art in paediatric heart transplantation: the Berlin experience;European Journal of Cardio-Thoracic Surgery;2012-11-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3